|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/137 | (2006.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 31/19 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 3261640 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16756282.6 |
| Date of filing the European patent application | 2016-02-24 | |
| (97) | Date of publication of the European application | 2018-01-03 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
| (46) | Date of publication of the claims translation | 2022-07-11 |
| (86) | Number | PCT/US2016/019368 |
| Date | 2016-02-24 |
| (87) | Number | WO 2016/138138 |
| Date | 2016-09-01 |
| (30) | Number | Date | Country code |
| 201562120726 P | 2015-02-25 | US |
| (72) |
BARABAN, Scott, C. , US
|
| (73) |
The Regents of the University of California ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 5HT agonistai epilepsijos sutrikimų gydymui |
| 5HT AGONISTS FOR TREATING EPILEPSY DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2026-02-02 | 11 | 289.00 EUR |
| 2027-02-24 |